Fig. 2: Kaplan–Meier survival analysis for glioma patients with low and high gene expression in CGGA datasets.

a–l Comparison of Survival of Primary Glioma and Recurrent Glioma patients with high and low ZIC1, TMEM154, PRRX14, ITGA4, APOBEC3F, ADAM12, ANTXR2, PHLDA1, CALCRL, GALNT5, FANCD2, CD44 expression.